Internet Explorer 11 has been retired by Microsoft as of June 15, 2022. To get the best experience on this website, we recommend using a modern browser, such as Safari, Chrome or Edge.
Work by a team of Scripps-lead scientists is revealing both the promises and challenges of using cutting-edge genetic technology to diagnose and treat diseases.
Scripps announced clinical research using genome sequencing to help identify causes of idiopathic human diseases: rare, serious conditions that defy diagnosis.
Scripps Clinic and The Scripps Research Institute (TSRI) began research for a proposed clinical trial using induced stem cells to treat Parkinson's disease.
A study by Scripps researchers examining a link between sleeping medications and early death and cancer was featured in a recent New York Times article.
Collaborating cancer physicians have successfully demonstrated the effectiveness of an advanced blood test for detecting and analyzing circulating tumor cells.
